SEC Form 4 research
| Issuer | AGIOS PHARMACEUTICALS INC |
|---|---|
| Tickers | AGIO |
| Reporting owners | 54 |
| Officers and directors | 20 |
| Last public filing | 2026-10-28 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-28 | 2026-10-26 | Gheuens Sarah | S | 7,866 | $37.69 | Not reported |
| 2026-10-23 | 2026-10-22 | Gheuens Sarah | S | 500 | $37.52 | Not reported |
| 2026-10-23 | 2026-10-21 | Gheuens Sarah | S | 1,489 | $37.53 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.